Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant

Protective immunity against SARS-CoV-2 infection after COVID-19 vaccination may differ by variant. We enrolled vaccinated (n = 39) and unvaccinated (n = 11) individuals with acute, symptomatic SARS-CoV-2 Delta or Omicron infection and performed SARS-CoV-2 viral load quantification, whole-genome sequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Seaman, Michael S., Siedner, Mark J., Boucau, Julie, Lavine, Christy L., Ghantous, Fadi, Liew, May Y., Mathews, Josh I., Singh, Arshdeep, Marino, Caitlin, Regan, James, Uddin, Rockib, Choudhary, Manish C., Flynn, James P., Chen, Geoffrey, Stuckwisch, Ashley M., Lipiner, Taryn, Kittilson, Autumn, Melberg, Meghan, Gilbert, Rebecca F., Reynolds, Zahra, Iyer, Surabhi L., Chamberlin, Grace C., Vyas, Tammy D., Vyas, Jatin M., Goldberg, Marcia B., Luban, Jeremy, Li, Jonathan Z., Barczak, Amy K., Lemieux, Jacob E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675445/
https://www.ncbi.nlm.nih.gov/pubmed/36214224
http://dx.doi.org/10.1172/jci.insight.159944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675445/
https://www.ncbi.nlm.nih.gov/pubmed/36214224
http://dx.doi.org/10.1172/jci.insight.159944

Ejemplares similares